Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline

Circulation Journal

Volumn 67, Issue 10, 2003, Pages 810-815

  Kakugawa, Hiroyuki ^a   Shimizu, Akihiko ^a   Yamagata, Toshihiko ^a   Esato, Masahiro ^a   Ueyama, Takeshi ^a   Yoshiga, Yasuhiro ^a   Kanemoto, Masashi ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Autocorrelation function; Cibenzoline; Spatial dispersion; Temporal dispersion

Indexed keywords

CIBENZOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY SINUS; DRUG INFUSION; ELECTROGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RIGHT ATRIUM; HUMAN; MALE; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0141995687     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.810     Document Type: Article

References (30)

1. Renma PL, Allessie MA, Lammers WJEP, Bonke FI, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dugs. Circ Res 1988; 62: 395-410.
2. Wang Z, Page PL, Nattel S. Mechanism of flecanide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992; 71: 271-287.
3. Wang J, Boume GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative mechanisms of antiarrhythmic drugs action in experimental atrial fibrillation. Circulation 1993; 88: 1030-1044.
4. Wijffels MCEF, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: The effects of cibenzoline, hydroquinidine, Recainide, and d-sotalol. Circulation 2000; 102: 260-267.
5. Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995; 92: 1193-1202.
6. Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O. Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procaninamide and propafenone: Importance of atrial fibrillatory cycle length. J Am Coll Cardiol 1990; 16: 1408-1414.
7. Biffi M, Boriani G, Bronzetti G, Capucci A, Branzi A, Magnani B. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart 1999; 82: 176-182.
8. Fujiki A, Nagasawa H, Sakabe M, Sakurai K, Nishida K, Mizumaki K, et al. Spectral characteristics of human atrial fibrillation waves of the right atrial free wall with respect to the duration of atrial fibrillation and effect of class I antiarrhythmic drugs. Jpn Circ J 2001; 65: 1047-1051.
9. Sih HJ, Ropella KM, Swiryn S, Gerstenfeld EP, Sahakian AV, Gerstenfeld EP, et al. Observation from intraatrial recording on the termination of electrically induced atrial fibrillation in humans. Pacing Clin Electrophysiol 1994; 17: 1231-1242.
10. Bollmann A, Kanum NK, McTeague KK, Walter PF, DeLurgio DB, Langberg JJ. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide. Am J Cardiol 1998; 81: 1439-1445.
11. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation: Spectral anaysis of fibrillation waves from surface electrogram. Circ J 2003; 67: 391-395.
12. Holm H, Pehrson S, Ingemansson M, Sornmo L, Jahansson R, Sandhall L, et al. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998; 38: 69-81.
13. Botteron GW, Smith JM. Quantitative assessment of the spatial organization of atrial fibrillation in the intact human heart. Circulation. 1996; 93: 513-518.
14. Ropella KM, Sahakian AV, Baerman JM, Swiryn S. The coherence spectrum: A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms. Circulation 1989; 80: 112-119.
15. Bendat J, Piersol A, editors. Basic descriptions and properties: Random data: Analysis and measurement procedures, 3rd edn. New York: John Wiley & Sons; 2000: 1-26.
16. Shimizu A, Yoshiga Y, Yamagata T, Esato M, Doi M, Kakugawa H, et al. New method of determining the atrial fibrillation cycle length during human atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14: (in press).
17. Shimizu A, Yamagata T, Ueyama T, Hayano T, Ohmura M, Tanura K, et al. Analysis of atrial electrograms during atrial fibrillation: Autocorrelofunction and interval of atrial electrograms. Jpn J Electrocardiol 1999; 19: 670-678.
18. Lai LP, Lin JL, Lien WP, Tseng YZ, Huang SK. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: Assessment of the electrophysiological effects by biatrial basket electrodes. J Am Coll Cardiol 2000; 35: 1434-1441.
19. Kim KB, Rodefeld MD, Schuessler RB, Cox JL, Boineau JP. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation 1996; 94: 2961-2967.
20. Rammanna H, Hauer RN, Wittkampf FH, de Bakker JM, Wever EF, Elvan A, et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. Circulation 2000; 101: 995-1001.
21. Gaita F, Calo L, Riccardi R, Garberoglio L, Scaglione M, Licciardello G, et al. Different patterns of atrial activation in idiopathic atrial fibrillation: Simultaneous multisite atrial mapping in patients with paroxysmal and chronic atrial fibrillation. J Am Coll Cardiol 2001; 37: 534-541.
22. Rammanna H, Elvan A, Wittkampf FH, de Bakker JM, Hauer RN, Robles de Medina EO. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J Am Coll Cardiol 2001; 37: 1403-1407.
23. Zrenner B, Ndrepepa G, Karch MR, Schneider MA, Schreieck J, Schomig A, et al. Electrophysiologic characteristics of paroxysmal and chronic atrial fibrillation in human right atrium. J Am Coll Cardiol 2001; 38: 1143-1149.
24. Wells JL Jr, Karp RB, Kouchoukos NT, MacLean WAH, James TN, Waldo AL. Characterization of atrial fibrillation in man: Studies following open heart surgery. Pacing Clin Elentrophysiol 1978; 1: 426-438.
25. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compare with procainamide during human atrial flutter and fibrillation: Electrophysiological determinants of enhanced conversion efficacy. Circulation 1997; 96: 4298-4306.
26. Slocum J, Sahakian A, Swiym S. Diagnosis of atrial fibrillation from surface electrocardiogram based on computer-detected atrial activity. J Electrocardiol 1992; 25: 1-8.
27. Gaita F, Riccardi R, Calo L, Scaglione M, Garberoglio L, Antolini R, et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation: Electrophysiological findings and ablation results. Circulation 1998; 97: 2136-2145.
28. Konings KT, Kirchhof CJ, Smeets JR, Wellence HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89: 1665-1680.
29. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia: III: The 'leading circle' concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977; 41: 9-18.
30. Sharpe MD, Dobkowski WB, Murkin JM, Klein G, Yee R. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Anesthesiology 1995; 82: 888-895.